J.M. Arbour’s Medtronic MDT Stock Holding History

J.M. Arbour’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$359K	Buy	4,592 +1,552	+51%	+$125K	0.31%	88
2026 Q1	$263K	Buy	3,040 +776	+34%	+$74.3K	0.25%	98
2025 Q4	$217K	Buy	+2,264	New	+$220K	0.22%	108

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

J.M. Arbour's MDT Position: Q2 2026 in Review

J.M. Arbour increased its Medtronic (MDT) stake by 51% in Q2 2026, buying an estimated $125K and bringing the position to 4,592 shares worth $359K. The position accounts for 0.31% of the portfolio, ranked #88.

J.M. Arbour first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. 2,147 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

J.M. Arbour held 4,592 shares of Medtronic worth $359K as of Q2 2026.
J.M. Arbour bought 1,552 Medtronic shares in Q2 2026, an estimated $125K.
Medtronic made up 0.31% of J.M. Arbour's portfolio in Q2 2026, its #88 holding.
J.M. Arbour first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
2,147 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J.M. Arbour's 13F filing for Q2 2026, filed 14 Aug 2026.